Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Other financing activities (2019 - 2022)

Historic Other financing activities for Volitionrx (VNRX) over the last 3 years, with Q4 2022 value amounting to $30196.0.

  • Volitionrx's Other financing activities changed N/A to $30196.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $112484.0, marking a year-over-year decrease of 7663.36%. This contributed to the annual value of $180472.0 for FY2022, which is 3837.12% up from last year.
  • Latest data reveals that Volitionrx reported Other financing activities of $30196.0 as of Q4 2022.
  • In the past 5 years, Volitionrx's Other financing activities ranged from a high of $333969.0 in Q1 2020 and a low of -$234998.0 during Q2 2019
  • Over the past 3 years, Volitionrx's median Other financing activities value was $84932.5 (recorded in 2019), while the average stood at $74409.2.
  • Over the last 5 years, Volitionrx's Other financing activities had its largest YoY gain of 28134.33% in 2020, and its largest YoY loss of 28134.33% in 2020.
  • Over the past 3 years, Volitionrx's Other financing activities (Quarter) stood at $147423.0 in 2019, then skyrocketed by 126.54% to $333969.0 in 2020, then tumbled by 90.96% to $30196.0 in 2022.
  • Its Other financing activities stands at $30196.0 for Q4 2022, versus $82288.0 for Q3 2022 and $333969.0 for Q1 2020.